These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 36538999)

  • 1. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
    Zhang Q; Wang Y; Liu F
    Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and therapeutic relevance of cancer-associated fibroblasts.
    Chen Y; McAndrews KM; Kalluri R
    Nat Rev Clin Oncol; 2021 Dec; 18(12):792-804. PubMed ID: 34489603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CAFs to overcome anticancer therapeutic resistance.
    Saw PE; Chen J; Song E
    Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
    Yoshida GJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer.
    Mishra D; Banerjee D
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Martinez-Zubiaurre I; Hellevik T
    Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts: from basic science to anticancer therapy.
    Yang D; Liu J; Qian H; Zhuang Q
    Exp Mol Med; 2023 Jul; 55(7):1322-1332. PubMed ID: 37394578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights.
    Chiu KJ; Chiou HC; Huang CH; Lu PC; Kuo HR; Wang JW; Lin MH
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning foes to friends: targeting cancer-associated fibroblasts.
    Chen X; Song E
    Nat Rev Drug Discov; 2019 Feb; 18(2):99-115. PubMed ID: 30470818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the devil: Strategies against cancer-associated fibroblasts in colorectal cancer.
    Chen Y; Liang Z; Lai M
    Transl Res; 2024 Aug; 270():81-93. PubMed ID: 38614213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
    Suzuki J; Tsuboi M; Ishii G
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment.
    Prieto-Fernández L; Montoro-Jiménez I; de Luxan-Delgado B; Otero-Rosales M; Rodrigo JP; Calvo F; García-Pedrero JM; Álvarez-Teijeiro S
    Biomed Pharmacother; 2023 May; 161():114502. PubMed ID: 37002578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis].
    Lunina NA; Safina DR; Kostrov SV
    Mol Biol (Mosk); 2023; 57(5):739-770. PubMed ID: 37752641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
    Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
    J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
    Guo J; Zeng H; Chen Y
    Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.